These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20179808)

  • 21. Comparison of subjective and objective hot flash measures over time among breast cancer survivors initiating aromatase inhibitor therapy.
    Otte JL; Flockhart D; Hayes D; Storniolo AM; Stearns V; Schneider B; Henry NL; Azzouz F; Nguyen A; Lemler S; Hayden J; Jeter S; Wright L; Carpenter JS
    Menopause; 2009; 16(4):653-9. PubMed ID: 19455068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis.
    Toulis KA; Tzellos T; Kouvelas D; Goulis DG
    Clin Ther; 2009 Feb; 31(2):221-35. PubMed ID: 19302896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer.
    Jacobson JS; Troxel AB; Evans J; Klaus L; Vahdat L; Kinne D; Lo KM; Moore A; Rosenman PJ; Kaufman EL; Neugut AI; Grann VR
    J Clin Oncol; 2001 May; 19(10):2739-45. PubMed ID: 11352967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenges in Treating Premenopausal Women with Endocrine-Sensitive Breast Cancer.
    Azim HA; Davidson NE; Ruddy KJ
    Am Soc Clin Oncol Educ Book; 2016; 35():23-32. PubMed ID: 27249683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acupuncture for the treatment of hot flashes in breast cancer patients, a randomized, controlled trial.
    Hervik J; Mjåland O
    Breast Cancer Res Treat; 2009 Jul; 116(2):311-6. PubMed ID: 18839306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can hypnosis reduce hot flashes in breast cancer survivors? A literature review.
    Elkins G; Marcus J; Palamara L; Stearns V
    Am J Clin Hypn; 2004 Jul; 47(1):29-42. PubMed ID: 15376607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients.
    Morales L; Neven P; Timmerman D; Christiaens MR; Vergote I; Van Limbergen E; Carbonez A; Van Huffel S; Ameye L; Paridaens R
    Anticancer Drugs; 2004 Sep; 15(8):753-60. PubMed ID: 15494636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of hot flashes in women with a previous diagnosis of breast cancer].
    Debourdeau P; Bachelot T; Zammit C; Aletti M; Gallineau C; Gligorov J
    Bull Cancer; 2004 Apr; 91(4):339-49. PubMed ID: 15242316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morning chronotype is a protective factor against chemotherapy-induced hot flashes in premenopausal women with breast cancer.
    Son KL; Jung D; Lee KM; Hwang H; Lee J; Kim TY; Im SA; Lee KH; Spiegel D; Hahm BJ
    Support Care Cancer; 2020 Mar; 28(3):1351-1358. PubMed ID: 31264189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hot flashes in breast cancer survivors.
    Hoda D; Perez DG; Loprinzi CL
    Breast J; 2003; 9(5):431-8. PubMed ID: 12968972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New therapeutic approaches for hot flashes in women.
    Stearns V; Loprinzi CL
    J Support Oncol; 2003; 1(1):11-21; discussion 14-5, 19-21. PubMed ID: 15352639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.
    Winer EP; Hudis C; Burstein HJ; Wolff AC; Pritchard KI; Ingle JN; Chlebowski RT; Gelber R; Edge SB; Gralow J; Cobleigh MA; Mamounas EP; Goldstein LJ; Whelan TJ; Powles TJ; Bryant J; Perkins C; Perotti J; Braun S; Langer AS; Browman GP; Somerfield MR
    J Clin Oncol; 2005 Jan; 23(3):619-29. PubMed ID: 15545664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase III evaluation of fluoxetine for treatment of hot flashes.
    Loprinzi CL; Sloan JA; Perez EA; Quella SK; Stella PJ; Mailliard JA; Halyard MY; Pruthi S; Novotny PJ; Rummans TA
    J Clin Oncol; 2002 Mar; 20(6):1578-83. PubMed ID: 11896107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.
    Goss PE; Ingle JN; Martino S; Robert NJ; Muss HB; Piccart MJ; Castiglione M; Tu D; Shepherd LE; Pritchard KI; Livingston RB; Davidson NE; Norton L; Perez EA; Abrams JS; Therasse P; Palmer MJ; Pater JL
    N Engl J Med; 2003 Nov; 349(19):1793-802. PubMed ID: 14551341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Standards, Options and Recommendations (SOR) for endocrine therapy in patients with non metastatic breast cancer. FNCLCC].
    Mauriac L; Blanc-Vincent MP; Luporsi E; Cutuli B; Fourquet A; Garbay JR; Giard S; Spyratos F; Zafrani B; Dilhuydy JM
    Bull Cancer; 2000 Jun; 87(6):469-90. PubMed ID: 10903789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential hormonal therapy for metastatic breast cancer after adjuvant tamoxifen or anastrozole.
    Carlson RW; Henderson IC
    Breast Cancer Res Treat; 2003; 80 Suppl 1():S19-26; discussion S27-8. PubMed ID: 14535531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic evaluation of aromatase inhibitors for the treatment of breast cancer.
    Alousi AM; Stano M; Simon MS
    Expert Rev Pharmacoecon Outcomes Res; 2003 Dec; 3(6):773-81. PubMed ID: 19807354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New developments in endocrine therapy: role of adjuvant therapy for early breast cancer.
    Grana G
    Cancer Nurs; 2003 Dec; 26(6 Suppl):4S-9S. PubMed ID: 15025406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current status of aromatase inhibitors in the management of breast cancer and critique of the NCIC MA-17 trial.
    Baum M
    Cancer Control; 2004; 11(4):217-21. PubMed ID: 15284712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.